NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 

Oncology news

Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project

Archive

Year: 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007


Czech National Cancer Registry is under threat
18. 12. 2007 Czech Society for Oncology Press Release | More information...

The Czech Society for Oncology (CSO), the Czech Ministry of Health (MZCR) and the General Health Insurance Company (VZP) have started negotiations on how to keep running the system for data collection, verification and storage within the National Cancer Registry (NCR).

Better prospect of recovery than 15 years ago
10. 12. 2007 Administrator | More information...

The prospect of cancer patients' recovery is much better than 15 years ago, as results from the conclusion of Czech oncologists and the Czech Statistical Office.

Board of the Czech Society for Oncology strongly protests against the outcomes of the EUROCARE-4 study
24. 8. 2007 Czech Society for Oncology Press Release | More information...

On 22th August 2007, the Czech public was misinformed about the allegedly poor treatment results of the Czech oncology, which had been published in the EUROCARE-4 study in the Lancet Oncology journal (Richards M. 2007. EUROCARE-4 studies bring new data on cancer survival. Lancet Oncol 8(9):752-753.).

Agreement between General Health Insurance Office and haematologists: right treatment to the right patient
13. 8. 2007 Administrator | More information...

The largest health insurance office (VZP) signed agreement with the Czech Society of Haematology (CHS) on a new way of costly therapy reimbursement.

Agreement on Understanding: a new way to finance the treatment of cancer patients.
1. 3. 2007 Administrator | More information...

On 26/02/2007, Jiri Vorlicek (President of the Czech Society for Oncology) and Pavel Horak (Director-General of the General Health Insurance Office) concluded the so-called "Agreement on Understanding", which is regarded as a historical milestone in the Czech oncology. Jiri Vorlicek assumes that other health insurance offices will join this initiative soon.


Back